Skip navigation
Cancer Immunotherapy at University of Hertfordshire - UCAS

Course options

2024 - 20252025 - 2026
Apply

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

This course is subject to validation. You can still apply for this course while it is being approved.

Course summary

Why MSc Cancer Immunotherapy at the University of Hertfordshire?

  • Employment prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.
  • Teaching excellence: You will be taught by Internationally renowned researchers who support research projects in Cancer Immunotherapy.
  • Sector-led course content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.
  • Work placement opportunities: You have a sandwich year pathway opportunity for you to enhance your employability.
The aim of the MSc in Cancer Immunotherapy is through an understanding of the numerous ways in which cancers and the immune system interact, to learn how cancer immunotherapies are developed. The utilisation of the immune system in cancer therapy has been a long-standing goal in the field. The course will provide a thorough understanding of immune effector mechanisms and of cancer biology and the personal skills the students will develop, through problem-based learning and self-directed learning. What will I study? Students will benefit from the research interests of the Bioscience Research Group including studies of the tumour microenvironment and communication with infiltrating immune cells, of methods tumours employ to diminish the effectivity of immune effector mechanisms and of how tumours communicate using Extracellular Vesicles with pre-metastatic sites. The taught modules in the programme will cover such topics as Adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade. Why choose this course? This course will provide you with the skills you need to have for future opportunities in the fast-growing cancer immunotherapy industry. It is an important discipline within the biomedical sciences and there is a high demand for well-qualified graduates. If you are a biomedical science, biology, or immunology graduate working in science, then this MSc programme will develop your skills and experience to facilitate your career progression, including future postgraduate study at MPhil/PhD level, with staff carrying out research in the cancer immunotherapy area. Our state of the art Science Building provides excellent facilities for laboratory-based studies, including cell culture and plate reader-based assays, isolated tissue studies, immunohistochemistry. What will I study? Students will benefit from the research interests of the Bioscience Research Group including studies of the tumour microenvironment and communication with infiltrating immune cells, of methods tumours employ to diminish the effectivity of immune effector mechanisms and of how tumours communicate using Extracellular Vesicles with pre-metastatic sites. The taught modules in the programme will cover such topics as Adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade. The course will be delivered through a combination of lectures, tutorials, practical classes and a research project and will utilise problem-based and self-directed learning. Students will also use case studies to encourage critical understanding. Through their research projects, carried out in the inspirational New Science Building and supervised by world-leading researchers, they will be trained in data collection, analysis and its interpretation. The Cancer Immunotherapy programme will also utilise expert external speakers from the biopharmaceutical industry.

Entry requirements

The normal entry requirements for the programme are: A first or second class Honours Degree in Biosciences or Biological Chemistry with a final classification grade of a minimum 55%; or A professional qualification accepted as equivalent to the above; or A qualification in veterinary science, medicine or dentistry; or A first or second class Honours Degree in disciplines other than those described above but where the applicant, in the opinion of the Programme Leader, would benefit from, and succeed on, the programme. In addition, all international students are required to demonstrate an English Language capability of IELTS 6.5 (with no less than 6.0 in any band) or equivalent qualification.

Fees and funding

Tuition fees

No fee information has been provided for this course

Tuition fee status depends on a number of criteria and varies according to where in the UK you will study. For further guidance on the criteria for home or overseas tuition fees, please refer to the UKCISA website .

Additional fee information

Fees for Postgraduate Study 2025/26 https://www.herts.ac.uk/study/fees-and-funding/fee-information/how-much-are-my-fees
Cancer Immunotherapy at University of Hertfordshire - UCAS